Company: CMND
Filing Date: 2025-09-15
Form Type: POS AM
Source: 0001213900-25-087398
Chunk: 36

Company: Clearmind Medicine Inc.
Filing Date: 2025-09-15
Form: POS AM
Chunk 36
---
 that the aggregate exercise price of the January 2024
PIPE Warrants shall remain unchanged.

Share Combination Event Adjustments. If
at any time on or after the date of issuance there occurs any share split, share dividend, share combination recapitalization or other
similar transaction involving our common shares and the lowest daily volume weighted average price during the five consecutive trading
days commencing on the date of such event is less than the exercise price then in effect, then the exercise price shall be reduced to
the lowest daily volume weighted average price during such five day period and the number of warrant shares issuable shall be increased
such that the aggregate exercise price payable thereunder, after taking into account the decrease in the exercise price, shall be equal
to the aggregate exercise price on the date of issuance. Such adjustment may only be made one time.

Transferability. Subject to applicable
laws, the January 2024 PIPE Warrants may be offered for sale, sold, transferred or assigned without our consent.

Exchange Listing. We do not intend to apply
to list the January 2024 PIPE Warrants on any securities exchange or nationally recognized trading system.

Fundamental Transactions. In the event
of a fundamental transaction, as described in the January 2024 PIPE Warrants and generally including any reorganization, recapitalization
or reclassification of our common shares, the sale, transfer or other disposition of all or substantially all of our properties or assets,
our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common shares, or any person
or group becoming the beneficial owner of more than 50% of the voting power represented by our outstanding common shares, the holders
of the January 2024 PIPE Warrants will be entitled to receive upon exercise of the January 2024 PIPE Warrants the kind and amount of
securities, cash or other property that the holders would have received had they exercised the January 2024 PIPE Warrants immediately
prior to such fundamental transaction without regard to any limitations on exercised contained in the January 2024 PIPE Warrants.

Rights as a Stockholder. Except as otherwise
provided in the January 2024 PIPE Warrants or by virtue of such holder’s ownership of our common shares, the holder of a January
2024 PIPE Warrant does not have the rights or privileges of a holder of our common shares, including any voting rights, until the holder
exercises the January 2024 PIPE Warrant.

Governing Law.